APA (7th ed.) Citation

Wang, L., Zhang, Y., He, Y., Li, J., Wang, T., Xie, Y., . . . Ouyang, T. (2021). Impact of dose-dense neoadjuvant chemotherapy on pathologic response and survival for HER2-positive breast cancer patients who receive trastuzumab. Nature Portfolio.

Chicago Style (17th ed.) Citation

Wang, Lize, Yang Zhang, Yingjian He, Jinfeng Li, Tianfeng Wang, Yuntao Xie, Zhaoqing Fan, and Tao Ouyang. Impact of Dose-dense Neoadjuvant Chemotherapy on Pathologic Response and Survival for HER2-positive Breast Cancer Patients Who Receive Trastuzumab. Nature Portfolio, 2021.

MLA (8th ed.) Citation

Wang, Lize, et al. Impact of Dose-dense Neoadjuvant Chemotherapy on Pathologic Response and Survival for HER2-positive Breast Cancer Patients Who Receive Trastuzumab. Nature Portfolio, 2021.